In addition to the core team, Farmantra collaborates with these industry experts who have made a mark in the Life sciences Industry. This provides us with strong credibility while executing challenging projects. Some of them who have been collaborating with us are:
Dr. Xavier Luria
Dr. Xavier Luria is the Chair and Senior Consultant at DDR Drug Development and Regulation based in Barcelona and London. He was Head of Safety and Efficacy of Medicines at the European Medicines Agency (EMA) during 2005-2012, and previously held leadership positions in the biopharmaceutical industry for more than eighteen years, covering international clinical development, pharmacovigilance, biostatistics and medical affairs.
In addition to Dr. Luria’s specialty in internal medicine, pharmaceutical medicine and biostatistics (University Autonomous Barcelona), he has developed expertise in several specific therapeutic areas, carried out postgraduate qualification in clinical pharmacology, drug development and regulation (Tufts University School of Medicine, Boston), he is a recognized expert on regulatory systems and benefit-risk assessment (modelling, development and methodologies) and has been lecturer at the UCSF.
Furthermore, he is consultant for governments in Europe and Latin America and professor of Regulation of Life Science Industry at the IE Business School and lecturer at several other academic institutions in Europe and USA. He is currently member of the Kinesys Advisory Board, scientific and regulatory advisor at TFS, Premier Expert Consultant at NDA Partners , Senior Advisor and UK representative of SFL, and he is also member of the European Advisory Board of RAPS
At Farmantra, Dr. Luria collaborates on evaluating regulatory risks of the products during valuation of the products/technologies.
Mr. Raj Airey is the founding partner of Wizzcare Home Health Solutions and was previously CEO of Baxter India region,(NYSE:BAX), a global diversified healthcare company. Mr. Airey brings 26 years of experience in the pharmaceutical industry of which 17 were with Pfizer - including eight years in Country President roles in CEE countries. UK, Belgium, Hungary, Slovakia, Poland, Spain and India. In addition, Mr. Airey has chaired NGO’s and think-tank initiatives in the area of IPR and encouraging innovation as well as industry/trade associations. He has held several board positions and has experience in representing the R&D pharmaceutical sector in industry forums and public debate. A post graduate from London University and executive programs from Harvard Business School and INSEAD Paris, Mr. Airey has considerable management experience with a track record of building successful organizations in fast moving environments
At Farmantra, Raj collaborates on strategic projects, negotiations, training and M&A due diligence activities.
Antonio Guglietta MD, PhD, MBA. Over 30 years experience in science and over 20 years experience in the pharmaceutical industry during which occupied positions of increasing responsibility. He worked at the University La Sapienza in Rome, Italy, the National Institute of Enviromental Health Sciences in North Carolina, USA and the Parke-Davis Research Laboratories in Michigan, USA. In the period 2000-2012 he held the position of Director of R&D at Grupo Ferrer in Barcelona, Spain.
During his career, he successfully participated and/or supervised several drug discovery and development programs whose drug products reached the market or were licensed out. Author of about 200 publications (full articles and congress comunications), 4 books on different aspects of drug preclinical development and clinical development, 5 chapters in books and 32 patents granted and member of several international scientific organizations.
At Farmantra, Antonio collaborates on evaluating and guiding the R&D strategy of the clients and benchmarking products technically while valuing the biotech products.